Targeting Epstein-Barr virus to treat MS

This article was originally published here

Med (N Y). 2022 Mar 11;3(3):159-161. doi: 10.1016/j.medj.2022.02.005.

ABSTRACT

Epstein-Barr virus (EBV) is a putative trigger for multiple sclerosis (MS). Bjornevik et al. utilized longitudinal analysis of 10 million adults to strongly link MS to EBV infection1 and Lanz et al. identified clonally expanded B cells in MS that bind EBV EBNA1 and GlialCam.2.

PMID:35590190 | DOI:10.1016/j.medj.2022.02.005